Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 10, 2020
3 Stocks to Buy if Coronavirus Second Wave Hits

3 Stocks to Buy if Coronavirus Second Wave Hits

Will there be a second wave? Scientists around the world are evaluating that question out of concern for public health. Investors want to know what it means for their portfolios. Which stocks will do well if Coronavirus spikes again? Tickeron can give you some insight on that. By analyzing market trends from the first wave, you can predict behavior for the second.

Technology stocks have performed at historic levels this year, but the market is severely overbought. Third quarter earnings reports may bring some of those numbers back to earth. To compensate for that, look at performance during Q1 and Q2, the height of global Covid shutdowns. You should also evaluate twelve-month trends and sales projections for Q3.

Netflix will Continue to Climb

On January 1st, Netflix (NFLX) was trading at $323.57 a share. It bottomed out on March 16th, when it hit a 2020 low of $298.84. The virus was just beginning to impact the US economy. By mid-April, the US and all other affected countries were completely shut down. Netflix stock benefitted from the stay-at-home orders. It’s currently selling for over $500 per share. 

Tickeron Screener has Netflix listed as a strong buy, with a projection of bullish behavior in both the one-week and one-month categories. The one-year historical analysis shows a market cap gain of 33.05%. Yahoo Finance predicts that sales growth for the third quarter will be 21.60%. That’s pretty good, but another Coronavirus wave could make that number climb even higher.

Technical analysis shows that Netflix is definitely a buy, but does fundamental analysis agree? Some might argue that Amazon Prime is gobbling up all the market share, but Netflix is producing original content at a faster rate. Viewers need fresh content. Movie theatres aren’t re-opening any time soon, if ever. Netflix is a definite buy if we see a second wave.   

Amazon is the 300-Pound Gorilla in 2020

Sure, Tesla (TSLA) has made a lot of noise this year, but we’re not betting on them to thrive during a second wave. It’s possible that they are the most overbought stock of 2020. Amazon (AMZN), on the other hand, is a beast. After an annual low of $1849.09 on March 20th, Jeff Bezos’ brainchild has skyrocketed to over $3000 per share, an all-time high. 

Needless to say, Tickeron has Amazon listed as a strong buy as 3 major fundamental metrics are signaling for a bullish momentum: Profit VS Risk rating, Price Growth rating, P/E Growth rating. 

Yahoo Finance predicts Q3 sales growth at 22.20%. The one-year market cap growth is an astounding 58.42%. Those are King Kong sized numbers. They also make Amazon an unstoppable force, even if Covid-19 strikes again. That second wave may actually turn their growth rate into a tsunami. 

You don’t have to be a financial analyst to see this one. Between Amazon Prime Video and their online shopping platform, the FAANG giant holds all the cards if the world goes into shut-down mode again. Even if that doesn’t happen, the way people shop and live their lives has changed forever after the first wave. Amazon is in the best position to take advantage of that.  

Zoom has Outpaced Google Meet

It’s rare to see Google lose a fight, but they can throw in the towel on this one. Zoom (ZM) has outperformed them this year in every way. Surprisingly, the area that Google Meet fell short was user experience. They were simply unprepared for the sheer volume of users that descended upon them when the world went virtual. Zoom was ready for it.  

In the past six months, Zoom’s stock has shown a gain of 267%. Q2 earnings actually exceeded expectations, which were fairly high. Tickeron has it listed as a buy, not a strong buy, but the 200% annual increase in market cap suggests it may be undervalued. Increased usage in the corporate and government sectors also indicate a spike will happen if a second wave hits.

Zoom’s movement in the past few weeks has been somewhat volatile, so if you’re trading, go long. Or buy some call options. The Aroon Indicator entered an uptrend on July 7th, so neither strategy will hurt you. Video conferencing is the preferred method of communication going forward and Zoom is the clear leader in the field. This stock will thrive in Q3. 

Current price $269.52 is above $255.90 the highest resistance line found by A.I. Throughout the month of 06/07/20 - 07/08/20, the price experienced a +28% Uptrend. During the week of 06/30/20 - 07/08/20, the stock enjoyed a +4% Uptrend growth.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In 61 of 72 similar cases where ZM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.

 

Use Tickeron Ticker for Additional Research

You can look up any publicly traded stock by going to the Tickeron Ticker page and entering the trading ticker for that security. Most of the information we’ve provided you here comes from those pages and Tickeron Screener. Check out both today to be a more informed trader or long-term investor. It’s free to get started and there are training and practice tools for the newbie.  

Related Ticker: ZM

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for ZM turns positive, indicating new upward trend

ZM saw its Momentum Indicator move above the 0 level on July 31, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for ZM just turned positive on July 27, 2026. Looking at past instances where ZM's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

ZM moved above its 50-day moving average on July 31, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ZM crossed bullishly above the 50-day moving average on August 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZM advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 186 cases where ZM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ZM moved out of overbought territory on August 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ZM broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ZM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.116) is normal, around the industry mean (28.731). P/E Ratio (15.605) is within average values for comparable stocks, (80.819). ZM's Projected Growth (PEG Ratio) (4.214) is slightly higher than the industry average of (1.729). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (6.536) is also within normal values, averaging (77.792).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.32B. The market cap for tickers in the group ranges from 291 to 239.81B. SAP holds the highest valuation in this group at 239.81B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was -1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 9%. NIQ experienced the highest price growth at 49%, while NXTT experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -19%. For the same stocks of the Industry, the average monthly volume growth was 18% and the average quarterly volume growth was -46%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 76
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
ZM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of video-first communications platform and application

Industry PackagedSoftware

Profile
Details
Industry
Packaged Software
Address
55 Almaden Boulevard
Phone
+1 888 799-9666
Employees
7420
Web
https://www.zoom.com
Interact to see
Advertisement
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion. Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.
Gilead Sciences (GILD): Q4 2025 earnings due February 10, consensus EPS $1.83, revenue $7.68B. Growth driven by HIV franchise; oncology investments like Trodelvy may offer upside. Amgen (AMGN): Reported Q4 2025 EPS $5.29 vs $4.73 expected, revenue $9.9B (+9% YoY). Strong 2026 guidance: $37–38.4B revenue, $21.60–23.00 non-GAAP EPS.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
CME Group delivered record 2025 revenue of $6.52 billion, up 6% year-over-year. Q4 adjusted EPS of $2.77 exceeded expectations.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Q4 2025 revenue reached $12.5 billion, exceeding expectations, with growth portfolio sales up 16% year-over-year. Full-year 2025 revenue totaled $48.2 billion, supported by Eliquis, Opdivo, and newer products including Breyanzi and Camzyos.
KKR reported Q4 2025 adjusted EPS of $1.12, slightly below the $1.14 consensus estimate. The firm raised a record $129 billion in 2025, surpassing 80% of its $300 billion fundraising goal for 2024–2026.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.